Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
Recent health news highlights include U.S. agency participation in a WHO meeting despite a planned exit, the UK's approval of ...
If you struggle with vaginal dryness or sensitivity, sex and self-pleasure can become uncomfortable, and even painful .
Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) ...
When the FDA declared an Ozempic and Wegovy shortage, business boomed for pharmacies making cheaper, off-brand versions of ...
Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.
Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...
Ongoing trials of the next generation of weight loss drugs are revealing something unexpected: Some patients are losing too ...
The GLP-1 ad wars “Healthy Skepticism” comes weeks after Eli Lilly competitor and Ozempic-maker Novo Nordisk launched a print ...
Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.
Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...
Eli Lilly is airing an ad during the Academy Awards urging customers to adopt a health skepticism when marketed drug brands that are not FDA-approved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results